Publications
-
V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.
Takahashi K,
Makita N, Manaka K, Hisano M, Akioka Y, Miura K, Takubo N, Iida A, Ueda N, Hashimoto M, Fujita T, Igarashi T, Sekine T, Iiri T.
J Biol Chem.
2012;
287
(3):
2099-106
-
Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N,
Takahashi K, Akioka Y, Morooka M, Ogawa A, Tsuzuki K.
J Nephrol.
2009 Sep-Oct;
22
(5):
610-5
-
Children's toxicology from bench to bed--Drug-induced renal injury (1): The toxic effects of ARB/ACEI on fetal kidney development.
Sekine T,
Miura K, Takahashi K, Igarashi T.
J Toxicol Sci.
2009:
34 Suppl 2
SP245-50
-
Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker.
Miura K,
Sekine T, Iida A, Takahashi K, Igarashi T.
Pediatr Nephrol.
2009;
24
(6):
1235-8
-
Clinical features and mutational survey of NPHS2 (podocin) in Japanese children with focal segmental glomerulosclerosis who underwent renal transplantation.
Furue T,
Hattori M, Tsukaguchi H, Kitamura A, Oomori T, Ogino D, Nakakura H, Ashida A, Miura K, Hisano M, Takahashi K, Chikamoto H, Akioka Y, Sakano T.
Pediatr Transplant.
2008;
12
(3):
341-6
-
Outbreak of Salmonella oranienburg infection in Japan.
Miyakawa S,
Takahashi K, Hattori M, Itoh K, Kurazono T, Amano F.
J Environ Biol.
2006;
27
(1):
157-8
-
Long-term remission induced by corticosteroids, cyclophosphamide, and methotrexate in a patient with natural killer cell leukemia.
Manabe A,
Takahashi K, Shibata R, Takeuchi M, Morita M, Hosoya R.
Med Pediatr Oncol.
2000;
34
(3):
224-5
Help